Ondansetron Tablet, Orally Disintegrating
Product Images NDC 76420-056

2 FDA label images from Asclemed Usa, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 76420-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Ondansetronod Fig1)

Label (Ondansetronod Fig1)
Labels for Ondansetron ODT, USP 4mg orally disintegrating tablets by Enovachem Pharmaceuticals, with multiple package sizes shown: 4, 6, 10, 20, and 30 tablets. Distributed by Aurobindo Pharma USA, Inc. Each label includes NDC numbers, a barcode, QR code, and storage instructions. Tablets are described as white to off-white, round, embossed/debossed.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)
Chemical structure diagram of Ondansetron, showing its molecular framework with labelled functional groups and bonds, associated with the Ondansetron 4 mg orally disintegrating tablet by Asclemed USA, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.